key: cord-0888260-uvut9lo4 authors: Zhu, Fucun; Zhong, Yi; Ji, Huan; Ge, Ran; Guo, Lu; Song, Haiyang; Wu, Heming; Jiao, Pengfei; Li, Sheng; Wang, Chenxing; Du, Hongming title: ACE2 and TMPRSS2 in human saliva can adsorb to the oral mucosal epithelium date: 2021-09-29 journal: J Anat DOI: 10.1111/joa.13560 sha: f6148baa2f30f034ead3664a2e6c55de5ffbee5c doc_id: 888260 cord_uid: uvut9lo4 Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is primarily transmitted through droplets. All human tissues with the angiotensin‐converting enzyme 2 (ACE2) and transmembrane protease serines 2 (TRMPRSS2) are potential targets of SARS‐CoV‐2. The role of saliva in SARS‐CoV‐2 transmission remains obscure. In this study, we attempted to reveal ACE2 and TRMPRSS2 protein expression in human parotid, submandibular, and sublingual glands (three major salivary glands). Then, the binding function of spike protein to ACE2 in three major salivary glands was detected. The expression of ACE2 and TMPRSS2 in human saliva from parotid glands were both examined. Exogenous recombined ACE2 and TMPRSS2 anchoring and fusing to oral mucosal epithelial cells in vitro were also unraveled. ACE2 and TMPRSS2 were found mainly to be expressed in the cytomembrane and cytoplasm of epithelial cells in the serous acinus cells in parotid and submandibular glands. Our research also discovered that the spike protein of SARS‐CoV‐2 binds to ACE2 in salivary glands in vitro. Furthermore, exogenous ACE2 and TMPRSS2 can anchor and fuse to oral mucosa in vitro. Thus, the expression of ACE2 and TMPRSS2 in human saliva might have implications for SARS‐CoV‐2 infection. The SARS-CoV-2 has emerged as a global pandemic, causing a severe public health problem (Arshad et al., 2020) . Like other human respiratory coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and the middle east respiratory syndrome coronavirus, SARS-CoV-2 also belongs to genusβ of the coronaviridae, involving multiple organs and tissues of the body (Cui et al., 2019; Hui et al.2020 ). The angiotensin-converting enzyme 2 (ACE2), known as a functional receptor for SARS-CoV, was first reported by Li (Li et al., 2003) . Now, studies on SARS-CoV-2 have demonstrated that ACE2 also serves as the adsorption target for the SARS-CoV-2 spike protein 1 (Wan, et al., 2020) . The SARS-CoV and the SARS-CoV-2 spike protein 1 can bind to ACE2 located on the host cytomembrane, facilitating the fusion and entry of the virus. This can culminate the adsorption and infection of the virus in the host cell (Xiao et al., 2003) . The binding of the SARS-CoV-2 spike protein 1 to ACE2 protein of the host cell facilitates the entry of SARS-CoV-2 via TMPRSS2, a cytomembrane protease, and the deletion of TMPRSS2 can inhibit this process (Hoffmann et al., 2020) . Thus, all human organs with ACE2 and TMPRSS2 are potential infectious targets of SARS-CoV-2 (Chai et al., 2020; Chen, Zhao, et al., 2020; Chen, Zhou, et al., 2020; Fan et al., 2020; Huang et al., 2020; Liu et al., 2020; Patel et al. 2020; Xu et al., 2020) . Respiratory droplets are the most common transmission route of SARS-CoV-2 (Singhal, 2020) . It is reported that SARS-CoV-2 and SARS-CoV have been consistently detected in the infected patient's saliva (Azzi et al.2020; Wang et al.2004 ). The questionnaire for COVID-19 patients also indicated the functional abnormalities of salivary glands, such as hyposecretion (Chen, Zhao, et al., 2020; Chen, Zhou, et al., 2020) . Based on the public database and bioinformatic analysis, some studies have reported the expression of ACE2 and TMPRSS2 in human salivary glands (Pascolo et al., 2020; Song et al., 2020; Shamsoddin, 2020; Wang et al., 2020) . Only a couple of studies have demonstrated the presence of ACE2 in salivary glands just in the Chinese rhesus macaques and rats by histological method (Cano et al., 2019; Liu et al., 2011) . However, the distribution details of the ACE2 and TMPRSS2 in human salivary glands and saliva remain unexplored. In the current study, we have investigated ACE2 and TMPRSS2 distribution in major human salivary glands (parotid, submandibular, and sublingual glands) and the binding of ACE2 to the SARS-CoV-2 spike protein. We have also detected the expression of ACE2 and TMPRSS2 in human saliva and the anchoring and fusing function of exogenous ACE2 and TMPRSS2 to the oral mucosal epithelium in vitro. The current study aims to provide experimental evidence to expand the knowledge about the role of saliva in SARS-CoV-2 infection. We procured parotid (n = 6), submandibular (n = 6), and sublingual (n = 7) gland samples from adult patients afflicted with benign disorders of salivary glands. Samples were surgically resected in the Affiliated Stomatological Hospital of Nanjing Medical University (Table 1) . Saliva samples were collected from young healthy volunteers '(n = 8) parotid glands (Table 2) Salivary gland samples were homogenized on ice. The homogenate was crushed through the ultrasonication process. It was followed by centrifugation of homogenate at 5000 g for 5 min, and the supernatant was separated for further analysis. Protein estimation was done using Bicinchoninic Acid Kit (P0012, Beyotime, China). The SARS-CoV-2 spike protein (SARS-CoV-2 Spike S1-His Recombinant Protein, 40591-V08H3, Sino Biological, China) was diluted in PBS, and 1 ng/ well was added into 96-well plates (Corning, USA) followed by overnight incubation at room temperature (RT). These plates were washed three times with Tween 20 solution with 0.05% TBS. Wells were blocked with 1% BSA in PBS for 1 h at RT. The supernatant of salivary gland homogenate was added to each well in triplicate and incubated overnight at RT. The plate was washed four times with PBS. AEC2 antibody (ACE2, 500 ng/ml, ab15348, Abcam, USA) was used to detect ACE2 receptor-bound spike proteins, followed by a thorough wash with Tween 20 with TBS-0.05%, three times, and 30 min incubation at RT with the HRP labeled Goat anti-rabbit IgG (1:2000, A0277, Beyotime, China). ABTS liquid substrate solution (Sigma, USA) was used for color development as per the manufacturer's instruction. OD (405 nm) was measured using an ELISA plate reader with wavelength correction set to 650 nm. HPR-labeled BSA (SE063, Solarbio, China) and HRP labeled goat anti-rabbit IgG served as control. As the control for SARS-CoV-2 spike protein binding to ACE2 in human salivary glands, the homogenate of small intestine and breast tissue was used as the positive and negative control respectively. The dewaxed tissue sections were incubated with a drop of 3% H2O2 at room temperature for 10 min to block endogenous peroxidase activity and later washed with PBS three times. The primary antibody ACE2 (2 µg/ml, ab15348, Abcam, USA) and TMPRSS2 (1:2000, ab109131, Abcam, USA) were added to each slide and incubated at RT for 2 h. After incubation, these slides were washed three times with PBS solution and incubated with the secondary antibody HRP-labeled anti-mouse/rabbit polymer (GK800511-B, Genetech, China) at RT for 30 min and re-washed three times with PBS solution. Subsequently, the diaminobenzidine (DAB) solution (Genetech, China) was added to each slide and incubated for 5 min. The tissue sections were counterstained with hematoxylin, dehydrated with alcohol gradient, renders tissues transparent with xylene, and fixed with neutral gum. ACE2 and TMPRSS2 immunoreactivity was grouped by immunoreactive score (IRS) (namely immunointensity score (IS) and proportion score (PS)) selected by staining intensity and distribution respectively. IS was divided into negative (0), weak (1), moderate(2), or strong (3), whereas PS was segmented into negative (<25% of the cells were immunoreactive) and positive (>25% of the cells were immunoreactive). Histological tissues were evaluated by two pathologists, respectively. The positive and negative control tissue sections were stained using primary antibodies (ACE2 for small intestine and breast tissue, 2 µg/ml, ab15348, Abcam, USA; TMPRSS2 for prostate adenocarcinoma and adipose tissue, 1:2000, ab109131, Abcam, USA) and secondary antibody (HRP-labeled anti-mouse/rabbit antibody) respectively. The control without primary antibody was stained using HRP-labeled anti-mouse/rabbit antibody. The isotype control was stained using normal rabbit IgG (700 ng/ml, A7016, Beyotime, China) and HRP-labeled anti-mouse/rabbit antibody. All the statistical analysis was done using SPSS version 22.0 (IBM-Corp., USA). The difference between the three groups was analyzed by one-way analysis of variance. SNK-q test was used to make multiple comparisons. p < 0.05 was considered to be statistically significant. Both ACE2 and TMPRSS2 were found to be expressed in salivary glands; however, their expression levels were significantly different among the three salivary glands. Lower than the ACE2 expression of the parotid glands, the ACE2 in submandibular glands and sublingual glands were 1.34 ± 0.05-Fold (F) (p = 0.027) and 1.81±0.13-F (p = 0.003) respectively (Figure 1a) . Lower than the TMPRSS2 expression of the parotid glands, the TMPRSS2 in submandibular and sublingual glands were 1.52 ± 0.03-F (p = 0.001) and 4.85 ± 0.02-F (p < 0.001) respectively (Figure 1b) . The expression of ACE2 was positive in small intestine and negative in breast tissue (Figure 1d ). The expression of TMPRSS2 was positive in prostate adenocarcinoma and negative in adipose tissue ( Figure 1d ). This result also confirmed the specificity of primary antibodies (ACE2 and TMPRSS2) used in this study. Salivary glands only stained by the secondary antibody were negative (Figure 1d ). We observed that the spike protein of SARS-CoV-2 could bind to human salivary glands (parotid, submandibular, and sublingual glands). ELISA of salivary gland homogenate supernatant demonstrated that the ACE2 could bind to the spike protein of SARS-CoV-2 ( Figure 2a-c) . As the control for the spike protein of SARS-CoV-2 binding to ACE2 in human salivary glands, the spike protein of SARS-CoV-2 was positively absorbed to the homogenate of small intestine and negatively absorbed to breast tissue (Figure 2d ,e). The brownish-yellow ACE2 ( Figure 3a ) and TMPRSS2 (Figure 3b) immune-complex were observed in the cytoplasm and cytomembrane of epithelial cells from serous acinus, intercalated, secretory, and excretory ducts. The vascular endothelial cells were positively immunostained for the ACE2 immune complex (Figure 3a ). ACE2 and TMPRSS2 complex staining was scored as 3 in parotid glands. The mucinous acinar cells were found to be negatively immu- Intestinal villi were observed in the mucosal layer of the small intestinal epithelium (Figure 4a ). The brownish-yellow ACE2 immune complex was observed in the small intestinal epithelium, which was used as the positive control for ACE2 immunostaining (Figure 4b ). Normal breast tissue with luminal cells was surrounded by a basal layer of myoepithelial cells by HE staining (Figure 4c ). There was no brownish-yellow ACE2 immune complex observed in breast tissue ( Figure 4d ). Adenocarcinoma of the prostate (Gleason grade 3 + 4 = score of 7) presented with single, separate, well-formed glands in the prostate (Figure 4e ). Prostate adenocarcinoma was positive for the brownish-yellow TMPRSS2 immune complex, as the positive control for TMPRSS2 immunostaining (Figure 4f ). H&E staining of mature adipocytes is presented in Figure 4g . There was no brownish-yellow TMPRSS2 immune complex observed in adipose tissue (Figure 4h ). The parotid, submandibular and sublingual glands, only incubated with HRP-labeled anti-mouse/rabbit antibody, were found to be negative for immunostaining (Figure 4i ). The parotid, submandibular, and sublingual glands, which were incubated with normal IgG and HRP-labeled anti-mouse/rabbit antibody, were also found to be negative for immunostaining (Figure 4j) . The outcomes of ELISA showed that the concentration of ACE2 and TMPRSS2 in saliva was 0.38 ± 0.03 ng/ml and 0.76 ± 0.18 ng/ml respectively. As the control, the expression of ACE2 was positive in the homogenate of small intestine (0.91 ± 0.12 ng/ml) and negative in the homogenate of breast tissue (0.11 ± 0.04 ng/ml); the expression of TMPRSS2 was positive in the homogenate of prostate adenocarcinoma (0.87 ± 0.10 ng/ml) and negative in the homogenate of adipose tissue (0.05 ± 0.03 ng/ml). The exogenous ACE2 and TMPRSS2 were found to exist in HOEC and HOK cells after incubating with recombinant human ACE2 and TMPRSS2 with His-tag. However, their expression levels were not significantly different between HOEC and HOK cells (Figure 5a,b) . This result also confirmed the specificity of primary antibodies (Histag) used in this study. A study in SARS-CoV infecting Chinese rhesus macaques has shown that the salivary glands of these animals possess ACE2, the function of which is affected by SARS-CoV infection (Liu et al., 2011) . (Chen, Zhao, et al., 2020; Chen, Zhou, et al., 2020) . There have been some studies confirming that ACE2 and TMPRSS2 are expressed in salivary glands. While the distribution details of the ACE2 and TMPRSS2 in human salivary glands still need to be explored (Pascolo et al., 2020; Song et al., 2020; Shamsoddin, 2020; Wang et al., 2020) . This is the first study to demonstrate the expression and distribution details of the ACE2 and TMPRSS2 in the acinus and ducts cells of the human parotid, submandibular, and sublingual glands. The brownish-yellow ACE2 immune complex was observed in the cytoplasm and cytomembrane of epithelial cells from serous acinar, sacral, secretory, excretory ducts, and vascular endothelial. (b) IHC of parotid glands for the detection of TMPRSS2 in parotid glands. The brownishyellow TMPRSS2 immune complex was observed in the cytoplasm and cytomembrane of epithelial cells from serous acinar, sacral, secretory, excretory ducts, and vascular endothelial. (c) IHC of submandibular glands for the detection of ACE2. The brownish-yellow ACE2 immunecomplex was mainly observed in the cytoplasm and cytomembrane of duct epithelial cells and serous acinus cells; the mucous acinar cells were negatively immunostained for the ACE2 immune complex. (d) IHC of submandibular glands for the detection of TMPRSS2. The brownish-yellow TMPRSS2 immune-complex was mainly observed in the cytoplasm and cytomembrane of duct epithelial cells and serous acinus cells; the mucous acinar cells were negatively immunostained for the TMPRSS2 immune complex. (e) IHC of sublingual glands for the ACE2 detection. The mucous acinar cells were found to be negatively immunostained for the brownish-yellow ACE2 immune complex; the ACE2 immune complex was observed in the cytoplasm and cytomembrane of serous acinar cells in the mixed acinus. (f) IHC of sublingual glands for the detection of TMPRSS2. The mucous acinar cells were found to be negatively immunostained for the brownish-yellow TMPRSS2 immune complex, which was observed in the cytoplasm and cytomembrane of serous acinar cells in the mixed acinus (black scale bar = 100 μm; black arrow: secretory duct; blue arrow: sacral ducts; yellow arrow: excretory ducts; red arrow: serous acinar cells) The spike protein of SARS-CoV and SARS-CoV-2 targeting ACE2 are highly similar in structure, and the fusion of both SARS-CoV and SARS-CoV-2 depends on TMPRSS2 (Bertram et al., 2012; Kuba et al., 2005; Li et al., 2003; Wan et al., 2020) . Thus, saliva may promote the infection of SARS-CoV. Our results confirmed that saliva contains ACE2 and TMPRSS2. The exogenous ACE2 and TMPRSS2 can absorb to oral mucosa epithelial cells. Based on results mentioned above, we hypothesized that the ACE2 and TMPRSS2 secreted into saliva from the cytoplasm of serous acinar cells in human salivary glands might anchor and fuse to oral mucosa epithelium, and perhaps they could contribute to SARS-CoV-2 infection in vivo. It is reported that live SARS-CoV-2 was detected in saliva. Moreover, saliva contains the three key elements (ACE2, TMPRSS2, and SARS-CoV-2) of SARS-CoV-2 infection . This is the first study demonstrating that ACE2 and TMPRSS2 are expressed in saliva and binds to oral mucosa epithelium. Therefore, saliva may be a promoter of SARS- Saliva is mainly composed of water and secreted by serous acinar cells, assisting in maintaining the moisture in the mouth, swallowing, and oral self-cleaning. In the resting state of saliva secretion, parotid glands account for 25%, and the submandibular glands account for 60%. However, in the highly stimulated state, parotid glands account for 50%, and the submandibular glands account for 35% of the total salivary secretion (Jensen et al., 1998) . Some SARS-CoV-2 infected patients develop a dry mouth and abnormal taste. And some other cases present oral necrotic ulcers and aphthous-like ulcerations, which develop early in the course of disease after the development of dysgeusia and affect the function of the tongue, lips, palate, and oropharynx. (Brandão et al. 2021; Chen, Zhao, et al., 2020; Chen, Zhou, et al., 2020) . The datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author upon reasonable request. Hongming Du https://orcid.org/0000-0002-0909-0773 The outbreak of coronavirus disease 2019 (COVID-19)-an emerging global health threat Saliva is a reliable tool to detect SARS-CoV-2 Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection Detection of SARSCoV-2 in saliva and characterization of oral symptoms in COVID-19 patients Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Origin and evolution of pathogenic coronaviruses Aquaporins in salivary glands: from basic research to clinical applications Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways 2020) ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Clinical features of patients infected with 2019 novel coronavirus in Wuhan The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan Salivary secretion: stimulatory effects of chewing-gum versus paraffin tablets A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury Identification of stem cells in the secretory complex of salivary glands Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Diverse progenitor cells preserve salivary gland ductal architecture after radiation-induced damage Diverse epithelial cell populations contribute to the regeneration of secretory units in injured salivary glands 2020) TMPRSS2 and ACE2 coexpression in SARS-CoV-2 salivary glands infection Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak -United States Saliva: a diagnostic option and a transmission route for 2019-nCoV 2020) A review of coronavirus disease-2019 (COVID-19) Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2 Consistent detection of 2019 novel coronavirus in saliva Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis? Medical Hypotheses Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis The SARS-CoV S glycoprotein: expression and functional characterization High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa